These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6792085)

  • 1. Tyrosinase immobilized within artificial cells for detoxification in liver failure: II. In vivo studies in fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1981 Mar; 4(2):82-5. PubMed ID: 6792085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats.
    Shi ZQ; Chang TM
    Trans Am Soc Artif Intern Organs; 1982; 28():205-9. PubMed ID: 6819667
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyrosinase immobilized within artificial cells for detoxification in liver failure: I. preparation and in vitro studies.
    Shu CD; Chang TM
    Int J Artif Organs; 1980 Sep; 3(5):287-91. PubMed ID: 6780470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
    Chirito E; Lister C; Chang TM
    Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro enzyme kinetics of microencapsulated tyrosinase.
    Yu B; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2002; 30(5-6):533-46. PubMed ID: 12537404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma/intestinal concentration patterns suggestive of entero-portal recirculation of amino acids: effects of oral administration of asparaginase, glutaminase and tyrosinase immobilized by microencapsulation in artificial cells.
    Chang TM; Lister C
    Biomater Artif Cells Artif Organs; 1988-1989; 16(5):915-26. PubMed ID: 3150943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc content in liver of experimental fulminant hepatic failure rat.
    Kawanishi H; Nishiki M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Sep; 32(3):305-9. PubMed ID: 6358141
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats.
    Shnyra A; Bocharov A; Bochkova N; Spirov V
    Artif Organs; 1991 Jun; 15(3):189-97. PubMed ID: 1867529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of hepatocytes cultured in microcarriers for correction of acute hepatic insufficiency].
    Bocharov AV; Fedina IB; Spirov VG; Bochkova NA; Shnyra AA
    Biull Eksp Biol Med; 1990 Jun; 109(6):590-2. PubMed ID: 2397302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternations of liver pathophysiology in experimental hepatic failure treated by two forms of plasma purification procedure.
    Ouchi K; Okabe K; Asanuma Y; Koyama K; Sato T
    Tohoku J Exp Med; 1985 Jun; 146(2):211-23. PubMed ID: 4024095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilirubin removal by hemoperfusion through carbon and by in vivo immobilized enzymes.
    Freston JW; Work JW; Denti E
    Kidney Int Suppl; 1976 Dec; (7):S229-32. PubMed ID: 827651
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
    Okabe K; Ouchi K; Koyama K; Sato T
    Trans Am Soc Artif Intern Organs; 1984; 30():395-8. PubMed ID: 6533913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of immobilized enzymes in an artificial liver support system.
    Brunner G; Holloway CJ; Lösgen H
    Artif Organs; 1979 Feb; 3(1):27-30. PubMed ID: 107930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-conventional treatment of hepatic failures.
    Sofer SS; Hare LH
    Int J Artif Organs; 1978 Nov; 1(6):270-9. PubMed ID: 367967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 19. Microencapsulated hepatocytes for bioartificial liver support.
    Cai ZH; Shi ZQ; O'Shea GM; Sun AM
    Artif Organs; 1988 Oct; 12(5):388-93. PubMed ID: 3056346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extracorporeal hemoperfusion in acute fulminant hepatic failure associated with paracetamol poisoning].
    Weiss LG; Danielson BG; Lööf L; Wikström B; Hedstrand U
    Lakartidningen; 1987 Apr; 84(18):1559-61. PubMed ID: 3626704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.